Breast Reconstruction Market Analysis | United States | 2017-2023 | MedCore

Breast Reconstruction Market Analysis | United States | 2017-2023 | MedCore


  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 7/1/2017
  • Pages: 530
  • Type: MedCore

General Report Contents
– Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
– Market Drivers & Limiters for each chapter segment
– Competitive Analysis for each chapter segment
– Section on recent mergers & acquisitions
There are two main types of breast reconstruction procedures: tissue expander/implant based procedures and autologous tissue procedures. Tissue expander/implant (TEI) procedures involve the use either of an artificial implant or a saline filled implant that is expanded over time as the patient heals. TEI procedures account for approximately 80% of breast reconstructions. The higher percentage of TEI procedures compared to previous years is related to the increasing incidence of bilateral reconstructions, because if a patient elects to have both breasts reconstructed, usually the TEI procedure is their only option due to the limited amount of tissue that can be harvested during autologous procedures. The remaining breast reconstructions were completed with autologous tissue using techniques, of which the most popular were transverse rectus abdominis myocutaneous (TRAM) flap, deep inferior epigastric perforators (DIEP) flap, and latissimus dorsi myocutaneous (LDM) flap. TRAM flap procedures were the most popular type of autologous breast reconstruction procedure in 2016, constituting about 40% of autologous procedures, whereas DIEP and LDM flap procedures accounted for approximately 28% and 32% respectively. Due to the increased amount of tissue, including a significant amount of muscle, required to fully reconstruct a breast, complications related to abdominal weakness are more likely to arise following autologous breast reconstructions than any other type of autograft procedure from different indications. The recent introduction of the free TRAM flap procedure, which was designed to minimize these post-surgery complications, has partially remedied this problem.

The "US Market Report Suite for Soft Tissue Reinforcement and Regeneration 2017 - MedSuite" includes analysis on the following companies currently active in this market:
C.R. Bard
Wright Medical
Integra LifeSciences
Smith & Nephew
Boston Scientific
Atrium Medical
Cook Medical
Johnson & Johnson
Soluble Systems
RTI Biologics
Zimmer Biomet
Aesculap/B. Braun
Gore Medical
Others include: Medline, MTF, WL Gore, Tutogen, Novus Scientific, Ariste Medical
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

Please fill out the all of the required fields and the captcha